NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $362,000 | +176.3% | 4,825 | +328.5% | 0.01% | +225.0% |
| Q3 2021 | $131,000 | -86.3% | 1,126 | -73.9% | 0.00% | -87.1% |
| Q2 2021 | $958,000 | +177.7% | 4,317 | +39.3% | 0.03% | -16.2% |
| Q3 2020 | $345,000 | +65.9% | 3,099 | -11.6% | 0.04% | +60.9% |
| Q2 2020 | $208,000 | +20700.0% | 3,505 | +24935.7% | 0.02% | – |
| Q3 2019 | $1,000 | -96.9% | 14 | -97.2% | 0.00% | -100.0% |
| Q2 2019 | $32,000 | +1500.0% | 503 | +1337.1% | 0.01% | +800.0% |
| Q1 2019 | $2,000 | -93.3% | 35 | -93.8% | 0.00% | -90.0% |
| Q3 2018 | $30,000 | – | 563 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |